| 000 | 01471 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250512114612.0 | ||
| 264 | 0 | _c19740308 | |
| 008 | 197403s 0 0 eng d | ||
| 022 | _a0090-4295 | ||
| 024 | 7 |
_a10.1016/0090-4295(73)90614-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMcVicar, M I | |
| 245 | 0 | 0 |
_aEditorial: Diffuse proliferative lupus nephritis. Evaluation of therapy. _h[electronic resource] |
| 260 |
_bUrology _cFeb 1973 |
||
| 300 |
_a174-6 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Controlled Clinical Trial; Journal Article | ||
| 650 | 0 | 4 |
_aAdrenal Cortex Hormones _xadministration & dosage |
| 650 | 0 | 4 |
_aAzathioprine _xtherapeutic use |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aCyclophosphamide _xtherapeutic use |
| 650 | 0 | 4 | _aDrug Evaluation |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin Fragments _xurine |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadverse effects |
| 650 | 0 | 4 |
_aLupus Erythematosus, Systemic _xdrug therapy |
| 650 | 0 | 4 |
_aNephritis _xdrug therapy |
| 650 | 0 | 4 | _aPlacebos |
| 650 | 0 | 4 |
_aPrednisone _xadministration & dosage |
| 650 | 0 | 4 | _aProspective Studies |
| 700 | 1 | _aSmithwick, E M | |
| 700 | 1 | _aFriedman, E A | |
| 773 | 0 |
_tUrology _gvol. 1 _gno. 2 _gp. 174-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0090-4295(73)90614-6 _zAvailable from publisher's website |
| 999 |
_c4593258 _d4593258 |
||